A recent report published by Infinium Global Research on bio surgery market provides an in-depth analysis of segments and sub-segments in the global as well as regional bio surgery market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional bio surgery market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global bio surgery market. According to the report, the global bio surgery market is projected to grow at a CAGR of 6.55% over the forecast period of 2019-2025.
Bio surgery is suitable for use on a variety of sloughy and necrotic wounds. Bio surgery also is known as larval therapy or maggot therapy. Sloughy wounds are a complex mixture of proteins, fibrin, serous exudates, bacteria, and leucocytes. Sloughy wounds are too thick to be removed by swabbing or irrigation as they are rapidly built upon the surface of previously clean wounds. Necrotic wounds rarely have high levels of exudate, and in this type of wounds, an alginate dressing is more suitable than a hydrogel or hydrocolloid dressing. Bio surgery is beneficial in several surgeries such as neurological and spine surgery, orthopedic surgery, and gynecology surgery.
The rising number of surgeries owing to the increasing rate of obesity and other lifestyle disorders drives the growth of bio surgery market. Growing diabetic patients boosts the growth of bio surgery market. Diabetic patients have difficulty in healing wounds. Maggot debridement therapy is one of the effective treatment for diabetic patients. According to NCBI, 60% of diabetic patients treated with maggot debridement therapy, erythema developed in normal skin surrounding the wound. Rising prevalence of cancer patients fuels the growth of bio surgery market. According to the world health organization, cancer is the second leading cause of death globally and it is estimated 9.6 million death in 2018. Moreover, the growing aging population and growing adoption of bio surgery products contribute to the growth of bio surgery market. However, high cost associated with surgeries and stringent government regulations may hamper the growth of bio surgery market. The rise in healthcare expenditure in the developing countries, such as India and China, provides beneficial opportunities for the growth of bio surgery market.
Among the geographies, North America dominates the bio surgery market followed by Europe. Growing adoption of advanced technologies, established healthcare sector as well as increasing investment in healthcare industry contribute to the growth of bio surgery market. Among the region, U.S holds a significant share in the bio surgery market. According to the world health organization, cervical cancer is among the most common types of cancer affecting women in the European Region, with 69 000 new cases and 30 000 deaths estimated for 2018 alone. Increasing prevalence of cancer, aging population and rising healthcare expenditure in the Europe region contribute to the growth of bio surgery market. Furthermore, the growth of bio surgery market in the Asia Pacific is expected to increase as the population is increasing in the region.
The report on global bio surgery market covers segments such as product, and application. On the basis of product, the sub-markets include surgical sealants, homeostatic agents, adhesive barriers, soft-tissue attachments, biological mesh, and other products. On the basis of application, the sub-markets include cardiovascular surgery, neurological and spine surgery, orthopedic surgery, gynecology surgery, general surgery, and other applications.
The report provides profiles of the companies in the market such as Baxter International Inc., C. R. Bard, Inc., Johnson & Johnson, Sanofi S.A, B. Braun Melsungen AG, Atrium Medical Corporation Company, Stryker Corporation, Homeostasis Laboratories, Inc., Pfizer Inc., CryoLife, Inc., and Other companies.
The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of bio surgery market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
2.1. Bio Surgery Market Highlights
2.2. Bio Surgery Market Projection
2.3. Bio Surgery Market Regional Highlights
3. Global Bio Surgery Market Overview
3.2. Market Dynamics
3.3. Porter's Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.4.1. IGR-Growth Matrix Analysis by Product
3.4.2. IGR-Growth Matrix Analysis by Application
3.4.3. IGR-Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Bio Surgery Market
4. Bio Surgery Market Macro Indicator Analysis
5. Global Bio Surgery Market by Product
5.1. Surgical Sealants
5.2. Homeostatic Agents
5.3. Adhesive Barriers
5.4. Soft-tissue Attachments
5.5. Biological Mesh
5.6. Other Products
6. Global Bio Surgery Market by Application
6.1. Cardiovascular Surgery
6.2. Neurological and Spine Surgery
6.3. Orthopedic Surgery
6.4. Gynecology Surgery
6.5. General Surgery
6.6. Other Applications
7. Global Bio Surgery Market by Region 2019-2025
7.1. North America
7.1.1. North America Bio Surgery Market by Product
7.1.2. North America Bio Surgery Market by Application
7.1.3. North America Bio Surgery Market by Country
7.2.1. Europe Bio Surgery Market by Product
7.2.2. Europe Bio Surgery Market by Application
7.2.3. Europe Bio Surgery Market by Country
7.3.1. Asia-Pacific Bio Surgery Market by Product
7.3.2. Asia-Pacific Bio Surgery Market by Application
7.3.3. Asia-Pacific Bio Surgery Market by Country
7.4.1. RoW Bio Surgery Market by Product
7.4.2. RoW Bio Surgery Market by Application
7.4.3. RoW Bio Surgery Market by Sub-region
8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global Bio Surgery Market
8.2. Companies Profiles
8.2.1. Baxter International Inc.
8.2.2. C. R. Bard, Inc.
8.2.3. Johnson & Johnson
8.2.4. Sanofi S.A
8.2.5. B. Braun Melsungen AG
8.2.6. Atrium Medical Corporation Company
8.2.7. Stryker Corporation
8.2.8. Homeostasis Laboratories, Inc.
8.2.9. Pfizer Inc.
8.2.10. CryoLife, Inc.
8.2.11. Other companies
9.1. Primary Research Findings and Questionnaire
Get free analyst support for the queries before and post purchasing report.
Be assured of 100% customer satisfaction about the research and get 24X7 customer support.
Infinium has achieved over 400%+ growth in its repository and revenue over the last 2 years. Yes, we are proud to say we are growing at a great pace and becoming a trusted partner among our clients.
sign up for our newsletter